Simona Signoriello
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
One-carbon metabolism nutrients and polygenic risk scores in relation to breast cancer risk: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Journal: The American journal of clinical nutrition
Published: March 19, 2026
Intake of the Total, Classes, and Subclasses of (Poly)phenols and Breast Cancer Risk: A Prospective Analysis of the EPIC Study.
Journal: Antioxidants (Basel, Switzerland)
Published: January 31, 2026
Evaluation of brucellosis eradication strategies in water buffalo in a key dairy production area of southern Italy.
Journal: Frontiers in microbiology
Published: November 06, 2025
Cost-effectiveness of protein restricted diets in advanced CKD.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: January 06, 2025
Decision Rules in Frequentist and Bayesian Hypothesis Testing: P-Value and Bayes Factor.
Journal: International journal of public health
Published: December 17, 2024
Circulating fatty acid binding protein 4 (FABP-4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study.
Journal: International journal of cancer
Published: November 20, 2024
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial.
Journal: The International journal of biological markers
Published: November 08, 2024
Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes.
Journal: Diabetes research and clinical practice
Published: October 19, 2023
Reply to Mocanu CA et al.
Journal: The American journal of clinical nutrition
Published: July 18, 2022
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab.
Journal: Diagnostics (Basel, Switzerland)
Published: July 18, 2022
Last Updated: 09/26/2026